Navigation Links
Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure
Date:1/8/2008

SAN MATEO, Calif., Jan. 8 /PRNewswire/ -- Corthera Inc. today announced the initiation of patient enrollment in a Phase II clinical trial of Relaxin, a naturally occurring peptide hormone that is being developed for acute heart failure and other acute care illnesses.

The trial will investigate the efficacy and safety of Relaxin in patients with acute heart failure. Approximately 330 patients will be recruited from more than 50 investigational centers worldwide. The primary outcome measure is the improvement of clinical signs and symptoms of acute heart failure, with additional secondary outcome measures, including improvement in renal function.

"With the current lack of safe and effective therapies for acute heart failure, we are very pleased to advance the development of Relaxin for the benefit of these patients," said Stan E. Abel, president and chief executive officer of Corthera. "The clinical and preclinical results to date are very encouraging, demonstrating Relaxin's beneficial hemodynamic properties."

According to the American Heart Association, heart failure is a costly cardiac and renal syndrome affecting more than 550,000 new patients per year, with projected direct and indirect costs at $33.2 billion in 2007. Acute heart failure is characterized by fluid overload (congestion), especially in the lungs, that causes shortness of breath and other complications. The current standard of care includes diuretics and vasodilators. Diuretics, which promote fluid excretion, are associated with renal complications. Vasodilators tested to date have been linked to hypotension, renal impairment and adverse outcomes.

About Relaxin

Relaxin is a naturally occurring peptide hormone that acts as a targeted vasodilator with demonstrated systemic and renal hemodynamic effects. Elevated levels of Relaxin are thought to modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent
'/>"/>

SOURCE Corthera Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
2. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
3. Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
4. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
5. Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia
6. Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
7. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
8. Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea
9. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Ranbaxy Laboratories Limited ... Ltd. (hereafter, Daiichi Sankyo), announced on May 22 ... years to address past conduct under prior management ... Daiichi Sankyo continues to support Ranbaxy in ... of the past which led to the investigations ...
(Date:5/22/2013)... Israel , May 22, 2013  Rosetta Genomics ... and provider of microRNA-based molecular diagnostics, announces that ... Executive Officer of Rosetta Genomics, will deliver a corporate ... from June 3-6, 2013 in New York City.  Mr. ... th at 2:00 p.m. Eastern time. ...
(Date:5/22/2013)... 22, 2013  BD (Becton, Dickinson and Company) (NYSE: ... company, announced today the publication of its 2012 ... and it continues to focus on the Company,s shared ... the principles of shared value — creating value for ... societies — are fundamental to our strategy," said ...
Breaking Medicine Technology:Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3BD Issues 2012 Sustainability Report 2BD Issues 2012 Sustainability Report 3
... March 18, 2011 BridgePoint Medical, Inc., a ... Denis Harrington has joined the company as President ... executive with nearly two decades of experience in ... commercialization of its CrossBoss™ Catheter and Stingray™ System. ...
... SHANGHAI, March 18, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: ... leading developer, manufacturer and distributor of probiotics products in ... an agreement with a US based nutritional product company. ... milestone in the China-Biotics, corporate history as it is ...
Cached Medicine Technology:BridgePoint Medical Names Industry Veteran as Chief Executive Officer 2China-Biotics Wins First US Customer 2China-Biotics Wins First US Customer 3
(Date:5/22/2013)... 2013 The newest member of TeethWhiteningforFree.com ... University of Alabama graduate, Dr. Sanderson provides professional dental ... TeethWhiteningforFree.com dentist, he extends complimentary teeth whitening to his ... and/or check up. Only a dental professional can decide ... whitening treatments. , Teeth whitening is an ...
(Date:5/22/2013)... John Theurer Cancer Center at Hackensack University Medical Center, ... bring together leading cancer experts, for presentation and discussion ... and interventional immunology in oncology, on Friday, June 7 ... bring together some of the nation,s top immunology experts ... therapies in oncology, both in solid and liquid tumors," ...
(Date:5/22/2013)... 2013 Spinal Elements, an innovative ... in Carlsbad to 3115 Melrose Drive, Suite 200, ... company’s continued and projected growth and has expanded ... feet to over 40,000 square feet. , ... indicated, “Our investment in these state-of-the-art facilities will ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The ... Rensselaer Polytechnic Institute today announced an affiliation agreement ... of new diagnostic tools and treatments that promote ... signing ceremony on May 22, 2013. , The ... in engineering and invention prototyping and Mount Sinai’s ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Many problems can ... deal of pain for a patient if left untreated. ... pain could be easily fixed through occlusal adjustment. A ... neck and back pain should have their dentist check their ... the bite and can lead to problems if the bite ...
Breaking Medicine News(10 mins):Health News:Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family 2Health News:Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies 2Health News:Spinal Elements®, Inc. Relocates Corporate Headquarters in Carlsbad 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 2Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 3Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 4Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 5Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 6Health News:Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration 7Health News:Dr. Martin N. Gorman: Make Headaches, Sensitive Teeth and Neck or Back Pain a Thing of the Past 2
... 17 LifeNet Health, a leading,biomedical and allograft ... Wound Allograft Institute" in affiliation with The Living ... and most progressive,organ and tissue recovery organizations in ... Institute" will directly serve the needs of burn,patients ...
... This release is available in French . ... use maps, satellite images, and other location-based or geospatial ... of Canada,s most pressing challenges, including public health. Through ... promoting this merger of geomatics with public health because ...
... 17 Fauquier Health,System of Warrenton, Virginia announces ... service professionals are all too familiar with,traveling to ... in the hopes of winning a sale. Vernon ... apply the health sytem,s long-standing,commitment to individualized patient ...
... quarters for St. Margaret,s Daughters, Home, NEW ORLEANS, ... Home in New Orleans will be reunited in a,temporary ... the wake,of Hurricane Katrina. The 116-bed eldercare facility ... the city,s Ninth Ward. While everyone at St.,Margaret,s was ...
... able to detect and treat Alzheimers Disease (AD) in ... degrees of cognitive impairment, thanks to new diagnostic criteria ... Lancet Neurology, the development of new guidelines was co-led ... Neurology in the University of British Columbias Faculty of ...
... of the 62nd United Nations General Assembly Tomorrow, September ... ... dying,of hunger every day and governments failing to meet their millennium,commitment to halve ... and hunger to play a,central role "on the table" of the 62nd United ...
Cached Medicine News:Health News:LifeNet Health Establishes 'The Skin & Wound Allograft Institute' 2Health News:Canada's government funds $1.6M in modern geography to support public health decisions 2Health News:Fauquier Health System Holds a Food Show with a Twist Long Term Care Patients Hold the Judge's Pen as Vendors Vie for Approval 2Health News:Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff 2Health News:Renovated New Orleans Care Facility Reopens, Reuniting Residents and Staff 3Health News:New way to diagnose Alzheimer's disease promises earlier treatment 2Health News:HungerFREE Campaign Tells UN: 'Put food on the table' 2
Corneal Marker - 8 blades, 2 sizes available: 7.0mm, 8.0mm. 1 piece per box...
... A new generation in automated semen analysis, ... push of a button. Automation provides standardization ... subjectivity out of semen analysis. SPERMALITE is ... parameters for remote semen analysis, and a ...
Stainless Steel. Sterile. 2 pieces/box...
... 4.5/5.0 mm Cannulated Screw System ... of modular systems developed by ... ranging from 3.5mm to 8.0mm. ... screws, the system was designed ...
Medicine Products: